The Phase 3 entry covering participants aged 6 to under 12 was last updated on 13 October 2026 and carries the status recruiting.
Bethesda, Maryland, 13 October 2026 — The ClinicalTrials.gov registry record for a Phase 3 interventional study sponsored by Eli Lilly and Company, identifier NCT07817875, was last updated on 13 October 2026. The overall status on the record is recruiting.
The registry returned 298 records in total for the search term tirzepatide on the day this wire was pulled. A registry record states what a sponsor has registered; it reports no result.
Source documents
-
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Identifier
- Registry identifier NCT07817875
- Registry status
- RECRUITING
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Last update posted
- 2026-10-13